Introduction
During orthodromic atrioventricular reentrant tachycardia (AVRT), ventricles are activated anterogradely through the atrioventricular node and retrogradely through an accessory pathway (AP). Antiarrhythmic drugs are initially used to prevent recurrences 1,2 of AVRT, whereas catheter ablation is frequently performed as a definitive treatment. 3 Occasionally, catheter ablation can be "proarrhythmic" if the AP is partially damaged but not completely eliminated. 4 A similar proarrhythmic effect has not been described with antiarrhythmic drugs in patients with an AP. In fact, the literature only describes the proarrhythmic effect of flecainide causing atrial flutter or ventricular tachycardia, 5, 6 but not the development of incessant supraventricular tachycardia in subjects with an AP. In the present report we describe a patient with Wolff-Parkinson-White syndrome due to a right paraseptal AP in whom the administration of flecainide resulted in an incessant form of AVRT resembling the permanent form of junctional reciprocating tachycardia.
Case report
A 16-year-old male subject with a structurally normal heart and a manifest right-sided AP consistent with a paraseptal location 5 ( Figure 1A ) presented with recurrent palpitations. A supraventricular tachycardia was documented with a cycle length of 220 msec (Figure 2A ). Initial treatment with beta blocker was ineffective in preventing recurrence of the tachycardia. He was then started on flecainide (50 mg every 12 hours). One week later, he had no recurrence of tachycardia and the electrocardiogram showed disappearance of ventricular preexcitation ( Figure 1B ). By performing carotid sinus massage and asking the patient to exercise, long and short sinus cycle lengths were obtained and confirmed that antegrade block over the AP was present over a wide range of sinus cycle lengths. Unexpectedly, 1 month after initiation of flecainide, he developed an incessant supraventricular tachycardia. When compared with the tachycardia observed before flecainide administration, under the drug the cycle length had now increased, from 220 to 320 msec, and the RP interval had increased from 80 to 120 msec ( Figure 2B ). Clear retrograde P waves were observed in inferior leads. Administration of repeated doses of adenosine (6-12-24 mg) only terminated the tachycardia transiently, with rapid reinitiation of the arrhythmia in the absence of atrial or ventricular premature beats ( Figure 2C ). In fact, a slight shortening of the PP interval was enough to reinitiate that tachycardia without a premature atrial or ventricular beat, resembling the permanent form of junctional reciprocating tachycardia. The supraventricular tachycardia was eventually terminated with intravenous amiodarone administration. The patient subsequently underwent an electrophysiology study after all antiarrhythmic drugs had been discontinued (Figure 3) , which confirmed the presence of a single AP with earliest ventricular activation recorded close to the anterior edge of the coronary sinus ostium. Orthodromic AVRT utilizing the AP as the retrograde limb was induced. Delivery of radiofrequency energy at this site eliminated AP conduction and the tachycardia could not be reinduced.
Discussion
In the present case, adenosine was initially successful in interrupting AVRT. However, once the electrophysiological properties of the AP were modified by flecainide, the patient developed an incessant tachycardia resembling the permanent form of junctional reentrant tachycardia, 7 which is secondary to an AP that only conducts retrogradely with slow conduction, providing the conditions of a stable reentry. One unique characteristic of the permanent form of junctional reentrant tachycardia is that upon occasional termination, the arrhythmia is rapidly reinitiated after a slight shortening of the sinus cycle length, in the absence of atrial or premature beats. This distinctive behavior was observed in the present case during flecainide administration, once the drug had eliminated antegrade conduction over the accessory A-V pathway and slowed, without abolishing, retrograde AP conduction, creating the conditions for an incessant tachycardia.
Our findings of preferential loss of antegrade conduction over the AP, with prolongation of the V-A interval during tachycardia, are consistent with the findings of Neuss et al. 8 These investigators showed that flecainide abolished antegrade conduction over the AP in 7 out of 12 patients. In contrast, retrograde conduction was eliminated in only 1 patient. In the present case, flecainide abolished antegrade conduction over the AP. The longer RP during tachycardia suggests that this drug slowed retrograde conduction, resulting in an incessant AVRT. However, because the electrophysiology study was performed after all antiarrhythmic drugs were discontinued, we cannot entirely rule out an alternative mechanism. Although previous cases of incessant AVRT had been reported in the literature, they are not related to flecainide or other class Ic antiarrhythmic agents as in the case herein presented. Littmann and Saxonhouse reported a case of incessant AVRT induced by the administration of metoprolol and diltiazem in a patient with a concealed leftsided AP. 9 In that case, these drugs slowed antegrade conduction over the AV node, facilitating retrograde conduction over the AP. In contrast, in the case now presented, flecainide blocked antegrade conduction while only slowing retrograde conduction over the AP, creating the conditions for an incessant tachycardia. 
KEY TEACHING POINTS
Flecainide administration in a patient with WolffParkinson-White syndrome and atrioventricular reentrant tachycardia resulted in suppression of antegrade conduction over the accessory pathway with slowing of retrograde conduction, creating the conditions for an incessant orthodromic atrioventricular reentrant tachycardia.
The present case illustrates the differential suppressive effect of antiarrhythmic agents over antegrade vs retrograde conduction of accessory pathways.
This was a proarrhythmic effect of flecainide associated with development of incessant supraventricular tachycardia. 
